U.S. flag

An official website of the United States government

NM_004004.6(GJB2):c.256A>G (p.Thr86Ala) AND not provided

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Sep 4, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV003569406.2

Allele description [Variation Report for NM_004004.6(GJB2):c.256A>G (p.Thr86Ala)]

NM_004004.6(GJB2):c.256A>G (p.Thr86Ala)

Gene:
GJB2:gap junction protein beta 2 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
13q12.11
Genomic location:
Preferred name:
NM_004004.6(GJB2):c.256A>G (p.Thr86Ala)
HGVS:
  • NC_000013.11:g.20189326T>C
  • NG_008358.1:g.8650A>G
  • NM_004004.6:c.256A>GMANE SELECT
  • NP_003995.2:p.Thr86Ala
  • LRG_1350t1:c.256A>G
  • LRG_1350:g.8650A>G
  • LRG_1350p1:p.Thr86Ala
  • NC_000013.10:g.20763465T>C
Protein change:
T86A
Molecular consequence:
  • NM_004004.6:c.256A>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: C3661900

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004320063Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Likely pathogenic
(Sep 4, 2023)
germlineclinical testing

PubMed (6)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

A rapid method for simultaneous multi-gene mutation screening in children with nonsyndromic hearing loss.

Du W, Cheng J, Ding H, Jiang Z, Guo Y, Yuan H.

Genomics. 2014 Oct;104(4):264-70. doi: 10.1016/j.ygeno.2014.07.009. Epub 2014 Aug 19.

PubMed [citation]
PMID:
25149764

Different functional consequences of two missense mutations in the GJB2 gene associated with non-syndromic hearing loss.

Choi SY, Park HJ, Lee KY, Dinh EH, Chang Q, Ahmad S, Lee SH, Bok J, Lin X, Kim UK.

Hum Mutat. 2009 Jul;30(7):E716-27. doi: 10.1002/humu.21036.

PubMed [citation]
PMID:
19384972
See all PubMed Citations (6)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV004320063.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (6)

Description

This sequence change replaces threonine, which is neutral and polar, with alanine, which is neutral and non-polar, at codon 86 of the GJB2 protein (p.Thr86Ala). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with nonsyndromic hearing loss (PMID: 25149764). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt GJB2 protein function. This variant disrupts the p.Thr86 amino acid residue in GJB2. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 19384972, 26763877, 30896630, 31160754). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 29, 2024